Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Objective: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a validated tool to assess risk of VTE in cancer patients. The purpose of this study is to determine if the Khorana score can be used as a risk stratification tool for VTE in patients...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rachael N. Piver, Vincent M. Wagner, Monica D. Levine, Floor J. Backes, Laura J. Chambers, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Christa I. Nagel, David M. O'Malley, Kristin L. Bixel
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-04-01
Edice:	Gynecologic Oncology Reports
Témata:	Chemotherapy Endometrial cancer Khorana score Thromboprophylaxis Uterine cancer Venous thromboembolism
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2352578923000255
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!